Nurix Therapeutics Inc. (NRIX)
11.41
0.94 (8.98%)
At close: Apr 02, 2025, 3:59 PM
Nurix Therapeutics Balance Sheet Statement
Financials in USD. Fiscal year
is
December - November.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| Period Ending | Nov 30, 2024 | Nov 30, 2023 | Nov 30, 2022 | Nov 30, 2021 | Nov 30, 2020 | Nov 30, 2019 | Nov 30, 2018 |
| Cash & Equivalents | 110M | 54.63M | 64.47M | 80.51M | 119.36M | 34.82M | 25.59M |
| Short-Term Investments | 499.59M | 233.28M | 244.67M | 215.21M | 161.79M | 2.9M | 13.45M |
| Long-Term Investments | n/a | 7.42M | 63.88M | 137.19M | 90.89M | 506K | 170K |
| Other Long-Term Assets | 4.06M | 4.72M | 4.92M | 3.12M | 347K | 317K | 151K |
| Receivables | n/a | n/a | n/a | 6.2M | 11.35M | n/a | n/a |
| Inventory | n/a | n/a | -1.1M | 1.00 | n/a | n/a | n/a |
| Other Current Assets | 9.8M | 7.59M | 9.31M | 1.1M | n/a | n/a | n/a |
| Total Current Assets | 619.39M | 295.5M | 318.45M | 311.12M | 298.43M | 39.35M | 40.65M |
| Property-Plant & Equipment | 45.9M | 47.95M | 29.51M | 25.34M | 6.67M | 3.87M | 4.42M |
| Goodwill & Intangibles | n/a | n/a | -3.3M | -3.33M | n/a | n/a | n/a |
| Total Long-Term Assets | 49.96M | 60.09M | 98.31M | 165.65M | 97.91M | 4.69M | 4.74M |
| Total Assets | 669.34M | 355.6M | 416.76M | 476.77M | 396.34M | 44.05M | 45.4M |
| Account Payables | 11.48M | 6.4M | 5.06M | 6.65M | 3.41M | 1.6M | 1.3M |
| Deferred Revenue | 38.36M | 48.1M | 37.63M | 41.21M | 32.8M | 9.61M | 28.42M |
| Short-Term Debt | 8.01M | 6.42M | 5.53M | 3.85M | n/a | n/a | n/a |
| Other Current Liabilities | 37.99M | 16.05M | 9.14M | 5.67M | 2.6M | 1.18M | 726K |
| Total Current Liabilities | 95.85M | 86.96M | 70.66M | 66.26M | 44.54M | 16.14M | 32.83M |
| Long-Term Debt | 20.29M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 26.21M | n/a | n/a | n/a | 850K | 49.93M | 49.41M |
| Total Long-Term Liabilities | 46.5M | 68.15M | 42.41M | 68.21M | 61.53M | 85.63M | 49.41M |
| Total Liabilities | 142.35M | 155.1M | 113.06M | 134.47M | 106.07M | 101.76M | 82.24M |
| Total Debt | 28.3M | 30.61M | 11.96M | 13.04M | n/a | n/a | n/a |
| Common Stock | 76K | 49K | 47K | 45K | 39K | 4K | 3K |
| Retained Earnings | -738.77M | -545.2M | -401.25M | -220.89M | -103.7M | -60.46M | -38.76M |
| Comprehensive Income | 150K | -655K | -4.32M | -608K | 87K | -2K | -4K |
| Shareholders Equity | 526.99M | 200.49M | 303.7M | 342.3M | 290.27M | -57.71M | -36.85M |
| Total Investments | 499.59M | 240.7M | 308.55M | 352.4M | 252.68M | 3.41M | 13.45M |